Qube Research & Technologies Ltd

Position in PRAX — Praxis Precision Medicines, Inc.

CIK 1729829 LONDON, X0

Position in PRAX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$41,313,779

-$8,466,922 QoQ

Shares Held

128,228

-24.1% QoQ

Ownership

0.460%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Qube Research & Technologies Ltd holds $2,030,208,323 across 186 Biotechnology names. PRAX ranks #11 (2.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	838,187	$277,330,932
2	FOLD	AMICUS THERAPEUTICS, INC.	8,809,340	$127,383,056
3	ROIV	Roivant Sciences Ltd.	3,450,904	$95,590,040
4	RPRX	Royalty Pharma plc	1,524,511	$73,130,792
5	REGN	Regeneron Pharmaceuticals, Inc.	83,358	$64,405,725
6	AXSM	Axsome Therapeutics, Inc.	335,334	$56,678,152
7	RVMD	Revolution Medicines, Inc.	553,290	$53,807,452
8	CYTK	Cytokinetics Inc	779,446	$51,373,285

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$41,313,779	128,228	-24.1%	Shares	Sole	2026-05-15
2025-12-31	$49,780,701	168,897	+194.7%	Shares	Sole	2026-02-17
2025-09-30	$3,037,112	57,304	+79.1%	Shares	Sole	2025-11-14
2024-12-31	$2,462,643	31,999	-28.4%	Shares	Sole	2025-02-14
2024-09-30	$2,572,210	44,703	-50.7%	Shares	Sole	2024-11-14
2024-06-30	$3,751,061	90,693	-31.8%	Shares	Sole	2024-08-14
2024-03-31	$8,112,120	132,942	+429.6%	Shares	Sole	2024-05-14
2023-12-31	$559,317	25,104	—	Shares	Sole	2024-02-13
No filing history on record for this holder in this stock.